GlassScriptPhysician profile
Erica Jefferies
NPI 1699262014
$1,832.13
in general payments reported to CMS, 2019-2025
17 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $276 · 2023: $310 · 2024: $479 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $592.50 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $255.15 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $154.79 | 2024-2025 | Voquezna |
| Acadia Pharmaceuticals INC | $134.84 | 2021 | |
| Axsome Therapeutics, INC. | $112.64 | 2024-2025 | Auvelity |
| Lilly USA, LLC | $105.53 | 2022-2023 | Mounjaro |
| Avanir Pharmaceuticals, INC. | $99.18 | 2021 | |
| Medtronic, INC. | $71.11 | 2023 | Kyphon Express II Kyphopak Tray |
| Pfizer INC. | $66.62 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.73 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.84 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $35.79 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $35.36 | 2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $20.96 | 2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.84 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.28 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $12.97 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Jefferies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.